Aeovian Pharmaceuticals, Inc. — Form D

Aeovian Pharmaceuticals, Inc. of Berkeley, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-28. The offering totals $3.8M, of which $786K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
David LoweDirectorWalnut Creek, CA
James PeyerDirectorNew York, NY
Ian MasseyExecutive OfficerNOVATO, CA
John J KincaidExecutive OfficerBerkeley, CA
Youssef J BennaniDirectorBerkeley, CA
Themasap J KhanDirectorBerkeley, CA
Nils J ReggeDirectorBerkeley, CA
Davis J RymanExecutive OfficerBerkeley, CA
William J GreeneDirectorBerkeley, CA
Micah J ZajicExecutive OfficerBerkeley, CA
Lars J EkmanDirectorBerkeley, CA
Justin J GoverDirectorBerkeley, CA
Allison J HulmeDirectorBerkeley, CA
Allison J HulmeExecutive OfficerBerkeley, CA
Richard J GasterDirectorBerkeley, CA
Richard GasterDirectorWaltham, MA
Davis C RymanExecutive OfficerBerkeley, CA
Nils C ReggeDirectorBerkeley, CA
Matthew J PlunkettExecutive OfficerBerkeley, CA
William C GreeneDirectorBerkeley, CA
John F KincaidExecutive OfficerBerkeley, CA
Richard C GasterDirectorBerkeley, CA
Lars C EkmDirectorBerkeley, CA
Jens EcksteinDirectorCambridge, MA
Ben ZadikExecutive OfficerSan Francisco, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2025-12-22D$55.0M$55.0M
2024-05-13D$50.4M$50.4M
2019-10-09D$48.8M$18.8M

More